Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial of CS-747 Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
This study has been completed.
Study NCT00059215   Information provided by Eli Lilly and Company
First Received: April 21, 2003   Last Updated: July 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
CS-747
Clopidogrel
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services